[{"NetIncomeLoss_1_Q1_USD":-5514000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"AccruedLiabilitiesCurrent_0_Q1_USD":1673000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":2000.0,"AccountsPayableRelatedPartiesCurrent_0_Q1_USD":20000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":23028000.0,"Depreciation_1_Q1_USD":4000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":254271000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":17630178.0,"PaymentsToAcquireInvestments_1_Q1_USD":5111000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":778000.0,"AssetsCurrent_0_Q1_USD":411754000.0,"DepositsAssetsCurrent_0_Q1_USD":90000.0,"TemporaryEquitySharesOutstanding_0_Q1_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2604000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":755000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q1_Security":1.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":1000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":28172000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":1805000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-154000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":4696000.0,"TemporaryEquityLiquidationPreference_0_Q1_USD":0.0,"TemporaryEquitySharesAuthorized_0_Q1_shares":0.0,"PrepaidExpenseCurrent_0_Q1_USD":298000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":166000.0,"CommonStockValue_0_Q1_USD":6000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q1_USD":170068000.0,"MarketableSecuritiesCurrent_0_Q1_USD":10646000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":1376000.0,"TemporaryEquitySharesIssued_0_Q1_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":378983000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-5668000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q1_USD":0.0001,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":400693000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":425435000.0,"Liabilities_0_Q1_USD":3848000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q1_pure":0.08,"ResearchAndDevelopmentExpense_1_Q1_USD":3875000.0,"CommonStockSharesIssued_0_Q1_shares":55617322.0,"ShareBasedCompensation_1_Q1_USD":647000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-17437000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":398314000.0,"CommonStockSharesOutstanding_0_Q1_shares":55042550.0,"InvestmentsFairValueDisclosure_0_Q1_USD":404145000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":9000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":3000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":647000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":150000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3697000.0,"LiabilitiesCurrent_0_Q1_USD":3706000.0,"AccountsPayableCurrent_0_Q1_USD":2033000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":400693000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":415000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":191000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_1_Q1_USD":124712000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":100000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":733000.0,"Assets_0_Q1_USD":411854000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":10644000.0,"StockholdersEquity_0_Q1_USD":408006000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"InterestReceivableCurrent_0_Q1_USD":27000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":801000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-5680000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":10646000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":254271000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":33000.0,"OperatingLeaseCost_1_Q1_USD":76000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":409000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":647000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":109000.0,"OperatingExpenses_1_Q1_USD":5680000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.31,"ProfitLoss_1_Q1_USD":-5514000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":142000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":411854000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":242000.0,"Ticker":"DSGN","CIK":"1807120","name":"DESIGN THERAPEUTICS, INC.","OfficialName":"Design Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"802639248.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]